This session will provide an overview of onychomycosis including causative agents as well as the role mail physiology plays in effectiveness of treatments.  The role of both topical and oral products will be examined as well as presentation on the role of JUBLIA (Efinaconazole) Topical Solution 10% for the treatment of onychomycosis.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.




James Q. Del Rosso, DO, FAOCD, FAAD

Dr. Del Rosso has been in clinical practice of dermatology for 35 years, 25 years in Las Vegas, Nevada. He has completed research, several teaching initiatives and presentations at major medical meetings, and has many publications in dermatology, with many on nail disorders including onychomycosis and antifungal therapy.

He is past president of the Council for Nail Disorders and is currently the Research Director and Principal Investigator at JDR Dermatology Research Las Vegas, Nevada and Senior Vice President of Clinical Research Strategic Development at Advanced Dermatology & Cosmetic Surgery in Maitland, Florida.

He also serves as Clinical Editor in Chief of the Journal of Clinical and Aesthetic Dermatology, a position he has held since the inception of the journal over a decade ago.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.